Kazia Therapeutics Limited (NASDAQ: KZIA) Stock Information | RedChip

Kazia Therapeutics Limited (NASDAQ: KZIA) Listen to this Section


$0.39
+0.0070 ( +1.82% ) 502.6K

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Market Data


Open


$0.39

Previous close


$0.39

Volume


502.6K

Market cap


$11.92M

Day range


$0.37 - $0.42

52 week range


$0.19 - $1.58

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 3 Jul 10, 2024
6-k Quarterly Reports 1 Jun 24, 2024
6-k Quarterly Reports 1 May 23, 2024
6-k Quarterly Reports 3 May 17, 2024
6-k Quarterly Reports 3 May 01, 2024
6-k Quarterly Reports 3 Apr 19, 2024
6-k Quarterly Reports 97 Mar 27, 2024
6-k Quarterly Reports 3 Mar 26, 2024
6-k Quarterly Reports 2 Feb 21, 2024
6-k Quarterly Reports 4 Jan 18, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.